Seminars in Arthritis and Rheumatism 1995-04-01

Quinidine-induced rheumatic syndromes.

J A Alloway, M P Salata

Index: Semin. Arthritis Rheum. 24(5) , 315-22, (1995)

Full Text: HTML

Abstract

Quinidine is a commonly used antiarrhythmic agent that is rarely associated with rheumatologic toxicity. However, quinidine-induced lupus, antinuclear antibody negative lupus-like syndrome, polymyalgia rheumatica-like illness, muscle weakness, and isolated creatine phosphokinase elevation have all been reported. We present one case of quinidine drug-induced lupus and another of a quinidine-induced polymyalgia rheumatica-like illness, and review the English literature for rheumatologic toxicity due to quinidine. Prompt recognition of quinidine associated rheumatologic toxicity is important because discontinuation of the medication leads to rapid resolution of clinical symptoms.


Related Compounds

Related Articles:

Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia.

1989-05-01

[DICP 23(5) , 375-8, (1989)]

Transfusion-transmitted malaria in a kidney transplant recipient. How safe is our blood transfusion?

2008-02-01

[Saudi Med. J. 29(2) , 293-5, (2008)]

Prospective comparison of intravenous quinidine and intravenous procainamide in patients undergoing electrophysiologic testing.

1998-07-01

[Am. Heart J. 136(1) , 49-56, (1998)]

Effect of dietary fat content on the bioavailability of a sustained release quinidine gluconate tablet.

1990-01-01

[Biopharm. Drug Dispos. 11(1) , 17-29, (1990)]

A 21-year-old woman from Africa with fever, anemia, and jaundice 7 days after arriving in the US.

2006-02-01

[J. Emerg. Nurs. 32(1) , 51-3, (2006)]

More Articles...